{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-026765","form_type":"8-K","ticker":"DNLI","cik":"0001714899","company_name":"Denali Therapeutics Inc.","filed_at":"2022-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.852422+00:00","generated_at":"2026-06-23T02:20:32.483905+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Denali Therapeutics prices $275M public offering of 10.4M shares at $26.50/share","bullets":["Priced 10,377,359 shares of common stock at $26.50 per share for gross proceeds of ~$275M.","Underwriters granted 30-day option to purchase up to an additional 1,556,603 shares.","Gross proceeds would be ~$316.2M if option exercised in full.","Offering expected to close on or about October 24, 2022, subject to closing conditions.","Goldman Sachs, J.P. Morgan, and Jefferies are joint book-running managers."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-026765","json":"https://secwatch.observer/filing/0001628280-22-026765.json","markdown":"https://secwatch.observer/filing/0001628280-22-026765.md","text":"https://secwatch.observer/filing/0001628280-22-026765.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1714899/000162828022026765/0001628280-22-026765-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1714899/000162828022026765/dnli-20221019.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:20:32.483905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}